Segment Information (Tables)

6 Months Ended

Dec. 31, 2013

Schedule of Segment Performance Measures

Six Months Ended December 31, 2013 and 2012:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2013
Net sales	$	78,511	$	85,903	$	81,355	$	-		$	245,769
Gross profit		24,168		23,035		13,515		-			60,718
Income (loss) before income taxes		11,727		14,530		5,453		(3,406	)		28,304

2012
Net sales	$	56,260	$	80,393	$	89,051	$	-		$	225,704
Gross profit		17,010		12,047		13,156		-			42,213
Income (loss) before income taxes		7,371		3,638		5,381		(1,670	)		14,720

Three Months Ended December 31, 2013 and 2012:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2013
Net sales	$	39,817	$	37,479	$	39,212	$	-		$	116,508
Gross profit		13,027		7,773		6,184		-			26,984
Income (loss) before income taxes		6,192		3,526		2,151		(1,139	)		10,730

2012
Net sales	$	29,851	$	39,785	$	44,320	$	-		$	113,956
Gross profit		8,907		5,471		6,330		-			20,708
Income (loss) before income taxes		4,252		1,085		2,296		(535	)		7,098

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details